Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2714 (LINC02714) is a member of the long intergenic non-coding RNA (lincRNA) class, a type of RNA molecule longer than 200 nucleotides that does not code for proteins and is transcribed from genomic regions that do not overlap protein-coding genes[1][6]. The specific biological functions, interacting drugs, roles in disease, or use as a biomarker for LINC02714 are currently not described in the published literature; however, lincRNAs in general can regulate gene expression by epigenetic modulation, chromatin remodeling, and transcriptional/post-transcriptional regulation[5][6]. LincRNAs have been described to play diverse roles in cellular differentiation, development, and disease pathogenesis, but such roles for LINC02714 remain uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2714 (LINC02714).